Marshall Stoller, MD


Dr. Marshall L. Stoller is medical director of the Urinary Stone Center at UCSF Medical Center that provides care for urinary stone disease including minimally invasive techniques or techniques requiring only small incisions such as endourology and laparoscopy. Stoller has helped spearhead a comprehensive program in the management of urinary stone disease, utilizing and testing a variety of lithotriptors, a non-invasive device that pulverizes urinary stones. Stoller is certified by the American Board of Urology. He has received many awards, including grand prize in the annual Lapides Essay Contest in Urodynamic and Neurourology Research.

Stoller graduated from the University of California at Berkeley in 1976 and went to medical school at Baylor College of Medicine in Houston, Texas. After medical school, he returned to the Bay Area, where he was a general surgical intern and resident and a urology resident at the University of California, San Francisco from 1981 to 1985. The following year, he became a clinical instructor and research fellow at the University of New South Wales at Prince Henry and Prince of Wales Hospitals in Sydney, Australia. Stoller returned to UCSF as chief resident in urology and then joined the medical staff. He is a professor in residence in urology and has received the Distinction in Teaching Award from the Academic Senate at UCSF.

For more information about his research, please visit Stoller’s lab website at


Urology Practice
400 Parnassus Ave., Sixth Floor, Suite A610
San Francisco, CA 94143
Phone: (415) 353-2200
Fax: (415) 353-2641

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Urology, American Board of Urology

Academic Title


More about Marshall Stoller


Baylor College of Medicine 1981


UCSF Medical Center, Urology 1987

Selected Research and Publications

  1. Isaacson D, Ahmad T, Metzler I, Tzou DT, Taguchi K, Usawachintachit M, Zetumer S, Sherer B, Stoller M, Chi T. Defining the Costs of Reusable Flexible Ureteroscope Reprocessing Using Time-Driven Activity-Based Costing. J Endourol. 2017 Sep 20.
  2. Graves CE, Co C, Hsi RS, Kwiat D, Imamura-Ching J, Harrison MR, Stoller ML. Magnetic Compression Anastomosis (Magnamosis): First-In-Human Trial. J Am Coll Surg. 2017 Aug 23.
  3. Bose N, Zee T, Kapahi P, Stoller ML. Mass Spectrometry-based in vitro Assay to Identify Drugs that Influence Cystine Solubility. Bio Protoc. 2017 Jul 20; 7(14).
  4. Usawachintachit M, Isaacson DS, Taguchi K, Tzou DT, Hsi RS, Sherer BA, Stoller ML, Chi T. A Prospective Case-Control Study Comparing LithoVue, a Single-Use, Flexible Disposable Ureteroscope, with Flexible, Reusable Fiber-Optic Ureteroscopes. J Endourol. 2017 May; 31(5):468-475.
  5. Wang RC, Addo N, Chi T, Moore C, Mallin M, Shiboski S, Stoller M, Smith-Bindman R. Medical expulsive therapy use in emergency department patients diagnosed with ureteral stones. Am J Emerg Med. 2017 Aug; 35(8):1069-1074.
  6. Zee T, Bose N, Zee J, Beck JN, Yang S, Parihar J, Yang M, Damodar S, Hall D, O'Leary MN, Ramanathan A, Gerona RR, Killilea DW, Chi T, Tischfield J, Sahota A, Kahn A, Stoller ML, Kapahi P. a-Lipoic acid treatment prevents cystine urolithiasis in a mouse model of cystinuria. Nat Med. 2017 Mar; 23(3):288-290.
  7. Mellema M, Stoller M, Queau Y, Ho SP, Chi T, Larsen JA, Passlack N, Fascetti AJ, Mohr C, Westropp JL. Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine. PLoS One. 2016; 11(12):e0166045.
  8. Hsi RS, Stoller ML. Complete Metabolic Evaluation is Indicated after a First Stone Event: Con. J Urol. 2017 Mar; 197(3 Pt 1):545-547.
  9. Tasian GE, Ross ME, Song L, Grundmeier RW, Massey J, Denburg MR, Copelovitch L, Warner S, Chi T, Killilea DW, Stoller ML, Furth SL. Dietary Zinc and Incident Calcium Kidney Stones in Adolescence. J Urol. 2017 May; 197(5):1342-1348.
  10. Tzou DT, Taguchi K, Chi T, Stoller ML. Animal models of urinary stone disease. Int J Surg. 2016 Dec; 36(Pt D):596-606.
  11. Chang HC, Tzou DT, Usawachintachit M, Duty BD, Hsi RS, Harper JD, Sorensen MD, Stoller ML, Sur RL, Chi T. Rationale and Design of the Registry for Stones of the Kidney and Ureter (ReSKU): A Prospective Observational Registry to Study the Natural History of Urolithiasis Patients. J Endourol. 2016 Dec; 30(12):1332-1338.
  12. Metzler IS, Smith-Bindman R, Moghadassi M, Wang RC, Stoller ML, Chi T. Emergency Department Imaging Modality Effect on Surgical Management of Nephrolithiasis: A Multicenter, Randomized Clinical Trial. J Urol. 2017 Mar; 197(3 Pt 1):710-714.
  13. Chi T, Usawachintachit M, Mongan J, Kohi MP, Taylor A, Jha P, Chang HC, Stoller M, Goldstein R, Weinstein S. Feasibility of Antegrade Contrast-enhanced US Nephrostograms to Evaluate Ureteral Patency. Radiology. 2017 Apr; 283(1):273-279.
  14. Hsi RS, Sanford T, Goldfarb DS, Stoller ML. The Role of the 24-Hour Urine Collection in the Prevention of Kidney Stone Recurrence. J Urol. 2017 Apr; 197(4):1084-1089.
  15. Sanford TH, Myers F, Chi T, Bagga HS, Taylor AG, Stoller ML. Emphysematous pyelonephritis: the impact of urolithiasis on disease severity. Transl Androl Urol. 2016 Oct; 5(5):774-779.
  16. Wang RC, Smith-Bindman R, Whitaker E, Neilson J, Allen IE, Stoller ML, Fahimi J. Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis. Ann Emerg Med. 2017 Mar; 69(3):353-361.e3.
  17. Hsi RS, Ramaswamy K, Ho SP, Stoller ML. The origins of urinary stone disease: upstream mineral formations initiate downstream Randall's plaque. BJU Int. 2017 Jan; 119(1):177-184.
  18. Hsi RS, Stoller ML, Miller NL. Ultrasonography is an Adequate Initial Screening Test for Urinary Calculi. J Urol. 2016 Sep; 196(3):645-7.
  19. Chi T, Usawachintachit M, Filippou P, Bayne D, Hu W, Chang H, Xia L, Chen Q, Xue W, He H, Long Q, Arsovska O, Taylor E, Paterson R, Sur RL, Chew B, Stoller ML, Li J. Significant differences in struvite and cystine stone frequency seen among Chinese nephrolithiasis patients living in North America compared to those living in China. Transl Androl Urol. 2016 Jun; 5(3):375-80.
  20. Truesdale MD, Elmer-Dewitt M, Sandri M, Schmidt B, Metzler I, Gadzinski A, Stoller ML, Chi T. Methylene Blue Injection as an Alternative to Antegrade Nephrostography to Assess Urinary Obstruction After Percutaneous Nephrolithotomy. J Endourol. 2016 Apr; 30(4):476-82.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.